Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Cash from Operations: 2021-2025

Historic Cash from Operations for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to $131.8 million.

  • Core Scientific's Cash from Operations rose 2206.69% to $131.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $139.0 million, marking a year-over-year increase of 173.63%. This contributed to the annual value of $42.9 million for FY2024, which is 34.12% down from last year.
  • As of Q3 2025, Core Scientific's Cash from Operations stood at $131.8 million, which was up 287.59% from $34.0 million recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Cash from Operations registered a high of $144.9 million during Q2 2022, and its lowest value of -$136.7 million during Q2 2021.
  • Over the past 3 years, Core Scientific's median Cash from Operations value was $18.0 million (recorded in 2023), while the average stood at $21.2 million.
  • Within the past 5 years, the most significant YoY rise in Core Scientific's Cash from Operations was 2,723.92% (2025), while the steepest drop was 283.09% (2025).
  • Over the past 5 years, Core Scientific's Cash from Operations (Quarterly) stood at $109.7 million in 2021, then increased by 5.69% to $116.0 million in 2022, then tumbled by 81.29% to $21.7 million in 2023, then crashed by 36.39% to $13.8 million in 2024, then spiked by 2,206.69% to $131.8 million in 2025.
  • Its Cash from Operations was $131.8 million in Q3 2025, compared to $34.0 million in Q2 2025 and -$40.6 million in Q1 2025.